Podcasts about Eoin

Eoin Everard is a physiotherapist with a PhD in Biomechanics. He's also a sub-4 minute miler, a sub-14 minute 5k runner, and a five-time Irish National Champion in the 1500 and 3000m. He also hosts the Better Running Podcast and is the cofounder of the BackAware Belt. Today's conversation focuses on plyometrics:  How can your average runner even get started with plyometrics Why you do NOT need advanced depth drops and other types of plyos The non-plyometric types of training that give you benefits just like plyos What types of shoes and surfaces to wear for plyometrics A lot more! Plyos demand strength so make sure you're strong before you attempt too many advanced plyos! Thanks for a great conversation, Eoin! Thank you Previnex! Get yourself 15% off your first purchase with code jason15 here. Previnex is a unique supplement company - one that I trust because they do things differently when they don't have to. Their products use clinically proven ingredients, are tested before and after formulation, and they donate vitamins to needy kids. Maybe more importantly, their products do what they say they're going to do. Listen to this feedback about Joint Health Plus! "My ankle and knee pain was completely gone in a week. Amazing!" - Kim "I thought I was on the verge of having to give up running due to severe hip pain and luckily discovered Previnex - complete game changer for me!" - Anna "I am so grateful for Joint Health Plus! As a certified fitness professional and still an extremely active, competitive amateur athlete, I was getting discouraged with an increase in pain simply kneeling down, or bending down to the floor and getting back up while assisting clients, or in my own training! Once deciding to give this product a try, I was floored when I finally noticed I was not bracing in anticipation of pain when I had to kneel down; not whincing in discomfort upon standing! Thank you, Prevenix!" - Jessica Joint Health Plus is so powerful because the main active ingredient is clinically proven to reduce joint pain, reduce joint stiffness, and improve joint flexibility in just 7-10 days. It's also clinically proven, not just tested, but actually proven in double-blinded, placebo- controlled studies to protect joint cartilage from breaking down during exercise. You can get 15% off your first Previnex purchase by using code jason15 at checkout. Visit previnex.com. Previnex offers a 30-day money back guarantee where if you don't feel benefits on their product you get your money back no questions asked. And keep sending in those testimonials. They fire me up! Thank you MOBO Board! Invented by renowned physical therapist Jay Dicharry, MOBO helps you stabilize your stance with an innovative rocker board that's set up on two fins. The design effectively forces you to drive your big toe into the board to improve your stability. I was pretty arrogant going into my first session on the MOBO Board. How hard can it be to balance, right? Well, I was humbled pretty quickly! Even if you're a good runner, better balance, stability, and proprioception is going to help you have a more powerful stride and prevent more running injuries. You'll learn how to improve the efficiency of the kinetic chain from your hip to your big toe. Because as Jay likes to say, it's not just how strong you are, but how well you use that strength. I was recently at a weekend physical therapy workshop (lol I was the only running coach) and learned how important (and rare) this simple movement is. Save 10% with code STRENGTHRUN10 at checkout at moboboard.com. Thanks to The Performance Training Journal! The Performance Training Journal is now available on Amazon and debuted as the #4 new release in the running category. Since I started running in 1998, I've kept a hardcopy training journal. Holding a tangible log, writing in it daily, and reflecting on the ups and downs of running is a surefire way to improve.  This hardcopy training journal helps you focus on the training metrics that matter, prioritizes a long-term outlook so you don't take any shortcuts, and maintains your motivation with strategic self-praise. With a no-frills, functional design, the Performance Training Journal includes coaching advice on racing, injury prevention, strength training, and more. It will guide you through race scheduling, how to plan your race morning, the best workouts for endurance runners, and encourage you to track your personal bests over time.  You have the space to make this journal your own whether you're a new runner or a professional, a trail or road runner, or a mid-distance specialist or ultra marathoner.⁣ So don't just track your running, learn from it with the Performance Training Journal! Check it out today on Amazon.

Welcome to the moon main event. Joe goes to war on behalf of the conspiracy community, and faces his regular fact checking foe.Are the missing moon tapes and JFK's missing brain linked? Who knows, but Joe has an idea - and even a suspect.Eoin initially opts for a gentler approach to the inevitable conflict with Joe, and he sets out on a search for common ground. But, of course, it fails and we are soon back on familiar ground.There's more allegations of Finglas moon thievery, and Joe has a suspect for that one too.We also bring you Darren freaking out over the thought of his iPhone floating through space for eternity, and Eoin celebrating a small win on his thankless quest for an acceptance of science.

Selling out two nights at Belfast's SSE Arena and new single The Sun Will Never Settle going straight to Number 1 - following their chart-topping album - you'd be forgiven for thinking Kingfishr are on top of the world on and off the stage. Eddie, Eoghan and Eoin tell us what's going on behind the scenes, the magic of their live show and how they wrote their banging new tune whilst driving around Ireland. Get in touch giles@mightymoonmedia.com Get yourself some top class Shure microphone gear: https://shu.re/3YhV7p2 Set up Your Band's merch store, for free at Distrokid Direct: https://distrokid.com/direct/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Tá maoiniú do €11.5 milliúin ceadaithe ag an Rialtas chun an togra INFOMAR a thabhairt chun críche, agus grinneal na farraige mórthimpeall na hÉireann á mhappáil acu mar chuid den dtogra seo.

Author Eoin Colfer and actor Garrett Lombard discuss Eoin's new play My Real Life.

Eoin Warner, láitheoir Wild Connemara ag labhairt faoin gclár a bhéas ar RTÉ Dé Domhnaigh.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

Cuimhní cinn acu ar an biaiste iascaireachta bradán deireannach i mBaile na nGall 20 bliain ó shin - blaiseadh ó thuairimí na ndaoine 2006 chomh maith.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JYN865. CME credit will be available until May 23, 2027.Electrophysiologic Insights Into Transthyretin Cardiac Amyloidosis: From Red Flags to Rhythm Control In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from BridgeBio Pharma, Inc.Disclosure information is available at the beginning of the video presentation.

Don Muchow has lived with Type 1 Diabetes for more than 50 years (@t1determined).But his story isn't just about Diabetes.At 42 years old, Don was overweight, struggling with his health, and already experiencing serious Diabetic complications before making a decision that completely changed the direction of his life.What started with exercise and small lifestyle changes eventually led to Ironman races, ultra-marathons, marathon swims, 200-mile cycling events, and even becoming the first and only known person with Type 1 Diabetes to run from Disneyland to Walt Disney World… covering 2,845 miles across America.In this episode, we talk about:Living with Type 1 Diabetes for over five decades.Overcoming complications later in life.Endurance training and blood sugar management.Fear around exercise and hypos.Aging with Type 1 Diabetes.Mindset, resilience, and consistency.What's actually possible with Diabetes long term.This is an incredibly honest, motivating, and practical conversation for anyone living with Type 1 Diabetes, especially those who feel like it may be “too late” to change their health.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

“You Had To Be There” is back with one of the OGs, as Eoin Sheahan sits down for a proper wander through the moments that shaped him — from Kerry, to DCU, to the early chaos of building Off The Ball Breakfast.There's the Kerry Mafia origin story, the ISDN box disaster, and why live broadcasting still gives the best buzz (even if the imposter syndrome was real).And then the list: Seánie O'Shea's iconic free in the 2022 All-Ireland semi, the heartbreak and madness of Ireland v New Zealand in Paris, missing Messi's World Cup triumph… and somehow ending up with one of Panama's unused subs in a Buenos Aires hotel.Off The Ball Breakfast with Viagra Connect 50mg film-coated tablets. Contains sildenafil. For adult men with erectile dysfunction. Subject to suitability. Maximum dosage one 50mg tablet per day. Always read the label.Catch The Off The Ball Breakfast show LIVE weekday mornings from 7:30am or just search for Off The Ball Breakfast and get the podcast on the Off The Ball app.SUBSCRIBE at OffTheBall.com/joinOff The Ball Breakfast is live weekday mornings from 7:30am across Off The Ball

Don Muchow has lived with Type 1 Diabetes for more than 50 years (@t1determined).But his story isn't just about Diabetes.At 42 years old, Don was overweight, struggling with his health, and already experiencing serious Diabetic complications before making a decision that completely changed the direction of his life.What started with exercise and small lifestyle changes eventually led to Ironman races, ultra-marathons, marathon swims, 200-mile cycling events, and even becoming the first and only known person with Type 1 Diabetes to run from Disneyland to Walt Disney World… covering 2,845 miles across America.In this episode, we talk about:Living with Type 1 Diabetes for over five decades.Overcoming complications later in life.Endurance training and blood sugar management.Fear around exercise and hypos.Aging with Type 1 Diabetes.Mindset, resilience, and consistency.What's actually possible with Diabetes long term.This is an incredibly honest, motivating, and practical conversation for anyone living with Type 1 Diabetes, especially those who feel like it may be “too late” to change their health.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Part 2 of Eoin's chat with Steven Cannady (@steven.cannady) to talk about the reality of living with Type 1 Diabetes for the past 21 years.Diagnosed at 13 years old, Steven shares the highs, lows, frustrations, and lessons that have shaped his journey, along with how running became something that gave him purpose, structure, and confidence.We also dive into the challenges of managing blood sugars while training for and completing 7 marathons, building Type 1 Diabetes Dash, and the mindset shifts that helped him stop seeing Diabetes as a limitation.A practical and honest conversation for anyone living with Type 1 Diabetes or trying to take better control of their health.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

In this episode, Eoin sits down with Steven Cannady (@steven.cannady) to talk about the reality of living with Type 1 Diabetes for the past 21 years.Diagnosed at 13 years old, Steven shares the highs, lows, frustrations, and lessons that have shaped his journey, along with how running became something that gave him purpose, structure, and confidence.We also dive into the challenges of managing blood sugars while training for and completing 7 marathons, building Type 1 Diabetes Dash, and the mindset shifts that helped him stop seeing Diabetes as a limitation.A practical and honest conversation for anyone living with Type 1 Diabetes or trying to take better control of their health.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

The Rebel News podcasts features free audio-only versions of select RebelNews+ content and other Rebel News long-form videos, livestreams, and interviews. Monday to Friday enjoy the audio version of Ezra Levant's daily TV-style show, The Ezra Levant Show, where Ezra gives you his contrarian and conservative take on free speech, politics, and foreign policy through in-depth commentary and interviews. Wednesday evenings you can listen to the audio version of The Gunn Show with Sheila Gunn Reid the Chief Reporter of Rebel News. Sheila brings a western sensibility to Canadian news. With one foot in the oil patch and one foot in agriculture, Sheila challenges mainstream media narratives and stands up for Albertans. If you want to watch the video versions of these podcasts, make sure to begin your free RebelNewsPlus trial by subscribing at http://www.RebelNewsPlus.com

Cuimhní cinn aige ar leathchéad bliain an tseachtain seo nuair d'fhág Tim Severin Cuas a'Bhodaigh agus iad ag triail ar Thalamh an Éisc.

Part 2 of Eoin's chat with Jye Warren (@the_average_athlete_), who was diagnosed with Type 1 diabetes at 25 years old and has spent the last 11 years navigating the highs, lows, and relentless mental demands that come with living with this condition every single day.One of the biggest turning points in Jye's journey came when his eyesight became impacted because of his diabetes. What started as a frightening wake up call quickly became a moment that forced him to confront the emotional weight, fear, uncertainty, and reality of living with a chronic condition that never truly switches off.In this conversation, we dive deep into how that experience affected him mentally and emotionally, the resilience it took to keep moving forward, and how it ultimately changed the way he approaches his health, mindset, and life.We also discuss the hidden mental load of Type 1 diabetes, burnout, identity, community, and why so many people living with diabetes feel pressure to appear like they are coping even when they are struggling internally.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

In today's episode, I sit down with Jye Warren (@the_average_athlete_), who was diagnosed with Type 1 diabetes at 25 years old and has spent the last 11 years navigating the highs, lows, and relentless mental demands that come with living with this condition every single day.One of the biggest turning points in Jye's journey came when his eyesight became impacted because of his diabetes. What started as a frightening wake up call quickly became a moment that forced him to confront the emotional weight, fear, uncertainty, and reality of living with a chronic condition that never truly switches off.In this conversation, we dive deep into how that experience affected him mentally and emotionally, the resilience it took to keep moving forward, and how it ultimately changed the way he approaches his health, mindset, and life.We also discuss the hidden mental load of Type 1 diabetes, burnout, identity, community, and why so many people living with diabetes feel pressure to appear like they are coping even when they are struggling internally.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Johnny is away in sunnier climes this week so Dan skips out to the southside of Dublin to catch up with friend of the show Eoin Doyle to get his impressions of the season so far. They talk best signings of the season and the best finishers in the league before unpicking the problems with Shelbourne and Derry City and delving into a mailbag that veers from student dilemmas to Graham Coughlan's impressive communication. All of this and more in association with our friends from Future Ticketing, Collar & Cuff, Planify and Rascals Brewing

Muinteoir and scoláirí Mhéanscoil San Nioclás – turas idirbhliana acu i gCorca Dhuibhne.

Beidh an ócáid, Darkness into Light ar siúl ag láithreacha éagsúla ar fud na tíre an deireadh seachtaine le haird a tharraingt ar chúrsaí meabhairshláinte, beidh siúlóid ar siúl i nGaoth Dobhair arís i mbliana.

What does the law expect us to do when another person is in immediate danger? And what happens when someone steps in to help — but is injured in the process? In this episode of LawPod, Dr Rosie Cowan and student host Eva Richards speak with Eoin Campbell, a Queen's graduate and lecturer in legal English in Lyon, France. Eoin shares a powerful and deeply personal account of intervening during a violent attack in a residential car park in France, where he and another passer-by helped save a young woman's life. The episode uses Eoin's experience to explore the legal and moral questions surrounding the duty to assist: a concept recognised in French criminal law, but approached very differently in UK and common law systems. Content note This episode includes discussion of a violent assault, strangulation, serious injury, trauma, post-traumatic stress, and the aftermath of criminal proceedings. Listener discretion is advised. About the episode In UK law, there is generally no broad criminal duty to rescue or intervene simply because another person is in danger. Duties to act usually arise only in particular situations — for example, where there is a special relationship, professional responsibility, assumption of care, or where a person has created a danger. French law takes a different approach (Article 223-6 of the French Penal Code). It recognises a more general obligation to assist a person in danger, provided that assistance can be given without serious risk to the rescuer or others. This principle is often discussed in terms of non-assistance à personne en danger — broadly, failure to assist a person in danger. Eoin's story brings this legal idea into sharp focus. His intervention was not abstract or theoretical. It happened in seconds, under pressure, and with serious consequences. The episode asks not only whether people should help, but also what support should exist for those who do. Key themes 1. The duty to assist in French law The conversation introduces the French idea that a person may have a legal duty to help someone in serious danger. That does not necessarily mean physically intervening in every case. Assistance might include calling emergency services, alerting others, or using available safety equipment. Eoin gives the example of seeing someone in difficulty in the sea. A bystander may not be required to swim out and risk their own life, but they may be expected to call for help or throw a life ring if one is available. This distinction matters: the law may encourage assistance, but it does not generally require a person to take unreasonable risks. 2. The limits of legal duties in moments of crisis One of the most striking parts of the episode is the gap between legal theory and real-life decision-making. As Eoin explains, when he saw the attack unfold, he was not weighing legal obligations or statutory wording. He saw someone in immediate danger and acted. That raises a difficult question: if the law says a person should help “if they can”, how realistic is it to expect someone to assess risk calmly in the middle of a violent emergency? The episode explores this tension between: legal duty;moral instinct;personal safety;public expectations; andthe reality of split-second decisions. 3. The UK and common law contrast Rosie places the discussion in its wider legal context by contrasting the French approach with the UK position. In common law systems, criminal liability is usually more cautious about punishing omissions — that is, failures to act. This does not mean that UK law is indifferent to people in danger. Rather, it tends to impose duties to act only in defined circumstances, such as where someone has responsibility for a child, patient, employee, or person in their care. The episode therefore raises a broader philosophical question: should law require solidarity between strangers, or should intervention remain primarily a matter of personal conscience? 4. Public messaging and state responsibility A central issue in the episode is whether public authorities can encourage people to intervene without also providing clear protection or support for those who are injured as a result. Eoin reflects on public campaigns urging people to challenge harassment, violence, and threatening behaviour. He does not reject the moral value behind those campaigns. Instead, he asks what should happen afterwards if someone does step in and suffers physical, psychological, or financial harm. This is one of the episode's most important questions: If the state encourages people to protect others, what duty does the state owe to the people who do the protecting? 5. Compensation, recognition, and procedural uncertainty Eoin also discusses the aftermath of the incident, including his hand injury, later diagnosis of PTSD, loss of earnings, and attempts to obtain recognition or compensation. His experience highlights the complexity of being neither the original target of the attack nor a conventional complainant, but someone injured while helping another person. The episode does not present this as a simple legal answer. Instead, it uses Eoin's experience to expose a possible gap between public expectations of bystander intervention and the systems available to support interveners afterwards. The discussion also touches on the importance of clear information for people involved in traumatic incidents: what to report, whether to seek medical evidence, how to preserve legal options, and where to find advice. Why this episode matters This episode is about more than one act of bravery. It asks how law understands responsibility between strangers. Most people would hope that if they were attacked, someone nearby would help. But the law has to answer harder questions. How much help can be expected? What if helping is dangerous? Does the answer change depending on a person's age, strength, training, or professional background? And if someone is injured while assisting, should they be treated as a victim too? Eoin's account makes these questions immediate and human. It shows that legal duties are not just rules in books. They operate — or fail to operate — in moments of fear, confusion, violence, and uncertainty. Questions explored in the episode Is there a legal duty to help a stranger in danger?How does French law differ from UK and common law approaches?What does “assistance” actually require?Does the law expect physical intervention, or can calling for help be enough?How should the law account for personal risk?Should someone injured while helping another person be entitled to compensation?What responsibilities do public authorities have when they encourage bystander intervention?Can law reflect moral solidarity without placing unrealistic burdens on individuals? Legal note This episode discusses legal concepts in general terms and through the personal experience of the guest. It is not legal advice. The legal position may depend on jurisdiction, factual context, procedural rules, and the specific wording of relevant legislation. Listeners facing similar issues should seek advice from a qualified legal professional in the relevant jurisdiction. Privacy and sensitivity note The episode discusses a real incident involving serious violence. Names and identifying details of private individuals involved in the attack are not used. The focus of the discussion is on the legal, ethical, and policy questions arising from the event.

This week's Addicted to Fitness features an interview with physical therapist and pilates instructor with a PhD in Human Movement Eoin Everard. Nick and Eoin discuss a variety of topics ranging from napping, digital detoxs, injury rehab, and muscle activation. Eoin also shares how he developed the BackAware Belt to help his patients maintain proper posture when they exercise. If you'd like to learn more about Eoin and his services, visit everardphysio.com and backawarebelt.com.  Follow the podcast profile on Instagram @TheATFPodcast. Give it a listen and let us know what you think by leaving a rating & review in Apple Podcasts. Visit addictedtofitness.libsyn.com to listen to our entire archive. Like & Follow the Addicted to Fitness Podcast Facebook page (Facebook.com/addictedtofitnesspodcast). Follow Nick & Elemental Training Tampa on Facebook (www.facebook.com/ElementalTampa) and Instagram (www.instagram.com/ettampa/) to participate in free live workouts. Follow the podcast profile on Instagram @TheATFPodcast and send Nick a DM if you're interested in receiving a customized workout plan or visit shannonjb.com (IG @shannonjb) to learn more about Shannon's wellness coaching program.

In March of this year the IRFU launched a series of combines to identify high potential athletes from other sports and introduce them to the elite rugby performance pathway.OTB's Susanna Mollen and Rachel Sheehan joined in at the second, Dublin-based combine in DCU where they chatted to a number of IRFU staff about the goals of the combines and potential backlash from other sporting organisations.Back in studio with Eoin, Susanna reports back on what news came out of the St. Pats campus. Want to watch the full piece? Check it out here: https://youtu.be/x18EaBVbGCU#Rugby is on Off The Ball with @BankOfIreland | #NeverStopCompeting--Listen to live League of Ireland commentary this Friday night as Bohemians do battle with Derry City at Dalymount Park.Phil Egan will be joined in the gantry by Keith Treacy, and you will be able to hear live and exclusive commentary on Off The Ball on Newstalk and the GoLoud App from 7 o'clock.Andy Dunne will be alongside Cuán Ó'Flatharta at the Aviva Stadium for live commentary of Leinster versus Toulon on Saturday May 2nd at 3 o'clock.You will be able to hear live commentary of that game on Off The Ball Saturday from 1pm on the GoLoud App and on Newstalk.Manchester United take on Liverpool in the Premier League on Off The Ball Sunday - former United star Darron Gibson will be alongside Stephen Doyle at Old Trafford for that one.That kicks off at half-past-three and you can follow all the action on Off The Ball Sunday from 1 o'clock on the GoLoud App and on Newstalk.

Eoin Walker is the HEMS segment promoter for Airbus, and host of The Pre-Hospital Care Podcast. With years of experience as a flight paramedic, Eoin has seen firsthand how good communication cools even the most heated scenarios.In this conversation, Eoin will let us in on how he's been able to harness his communication through his life and career, and what we can do to follow suit. How we can "be the thermostat, not the thermometer."

Mar fheirmeoir agus conraitheoir talmhaíochta cén ghlacadh atá aige leis an bpacáiste a fógraíodh inné.

Adrian Ó Coinceannain, Leas-Phríomhoide Choláiste Naomh Eoin ag labhairt faoin Inis Iron Meáin.

Eoin O'Duffy

PJ gets cost of living tips so you can still afford a nice holiday this year. See also here Hosted on Acast. See acast.com/privacy for more information.

PJ gets money saving advice, hears how a toll increase is causing traffic chaos in Fermoy, learns why manual licences might be better than licences for automatics. And more... Hosted on Acast. See acast.com/privacy for more information.

Join me for My Irish Whiskey Association Chat with Director Eoin O'Catháin. Eoin has been Director of the IWA for over 2.5 years. We sat for a chat in a busy Doheny & Nesbitt pub on Dublin's Baggot St, a real charming boozer in the heart of Dublin city.  Eoin and I chatted about how the IWA advocates for and protects the Irish Whiskey category internationally and went down many other rabbit-holes...  This episode of the podcast is sponsored by: www.boanndistillery.ie www.killowendistillery.com  www.theharbourviewhotel.com Don't forget to sign up to my Patreon channel for early access episodes and more, for a few euros a month and help me deliver the best podcasts to you. https://www.patreon.com/whiskeychatspodcast I really hope you enjoy listening in to our chat. Laurie

Familiarity with the clinical, MRI, CSF, and serologic features of MOGAD can help neurologists recognize this condition in clinical practice. Awareness of the utility and pitfalls of the MOG antibody test is critical. The current therapeutic approach is guided by retrospective studies and the application of immunotherapies used in other autoimmune neurologic disorders. In this episode, Gordon Smith, MD, FAAN, speaks with Eoin P. Flanagan, MBBCh, coauthor of the article "Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease" in the Continuum® April 2026 Multiple Sclerosis and Related Disorders issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Flanagan is a professor of neurology and the division chair of the Division of Multiple Sclerosis and Autoimmune Neurology in the Department of Neurology at Mayo Clinic in Rochester, Minnesota. Additional Resources Read the article: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @GordonSmithMD Full episode transcript available here Dr Smith: So, what neurological disorder can cause bilateral optic neuritis, transverse myelitis, ADEM, or can mimic acute flaccid myelitis, intracranial hypertension, viral encephalitis, or cause seizures? Sounds like the great imitator, perhaps. If you want to know and learn more about this syndrome and how you can treat it---and it is very treatable---keep listening. My name is Gordon Smith, and today I have the great opportunity to talk with Dr Eoin Flanagan from the Mayo Clinic on his article on myelin oligodendrocyte glycoprotein antibody associated disease, or MOGAD, which is in the April 2026 issue of Continuum on Multiple Sclerosis and Related Disorders.  Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Smith: This is Dr Gordon Smith. Today I'm interviewing Dr Eoin Flanagan about his article on myelin oligodendrocyte glycoprotein associated disease, or MOGAD, which appears in the April 2026 Continuum issue on multiple sclerosis and related disorders. Eoin, welcome to the podcast, and please introduce yourself to our audience.  Dr Flanagan: Yeah, thanks so much. I'm Eoin Flanagan. I'm a neurologist at the Mayo Clinic. I'm originally from Ireland. I work in the neuroimmunology lab at the Mayo Clinic, and work and see patients with MS, MOG, and autoimmune disorders here in Rochester, Minnesota.  Dr Smith: Your article is super interesting, I think, and this has been a really rapidly evolving area over the last, you know, many years. We have many more antibodies, and MOG is something that's been around for a while, but we've certainly learned a lot more about it. This is a topic that I think will be familiar to most of our listeners, but I wonder if maybe you can just begin by laying the foundation. Like, what is MOG? What's its typical presentation?   Dr Flanagan: So, MOG is a protein on the surface of the oligodendrocyte or its CNS myelin, and it was always of interest as a potential antibody target, and initially it was investigated in multiple sclerosis. But subsequently, we recognized that the antibodies to MOG have a specific syndrome, of which about a quarter of patients are pediatric and then the remainder are adults. And they can present with a variety of syndromes, probably most commonly optic neuritis, but also acute disseminated encephalomyelitis, or ADEM. Transverse myelitis can also occur, and then some other unusual brain and brainstem cerebellar syndromes can also occur.   Dr Smith: I was really impressed in the very broad phenotypic spectrum of MOG. We'll talk more about that, of course. But I wonder if maybe you can tell us when we should be ordering MOG antibody? Given this broad variability, does anyone who has a CNS demyelinating disease need a MOG assay, only specific phenotypes? What guidance do you have for our listeners?   Dr Flanagan: Yeah. It's a great question. So, I think you have to be a little bit careful because the MOG antibody test is a little bit sticky. So sometimes we can see some low-positive false positives. So, we don't wanna order it in every single patient with classical MS. So, I suppose we'll start with who not to order it in. I think it's also a very optic nerve- and optic neuritis-central disease, so I think you really need to be considering this in a patient with optic neuritis who does not have lesions in the brain suggestive of multiple sclerosis. And then we think about some of the features: if the lesion, the enhancement along the optic nerve is long, if it's bilateral, if there's a lot of optic disc edema accompanying that, we tend to think about MOG antibodies. And then children with demyelinating disease, MOG is over-represented in that cohort, so it accounts for about a third of those. So, if you have a child with CNS demyelinating disease, particularly if they're under twelve, with ADEM presentations or other presentations, you probably want to be ordering the MOG antibody test. And then a longitudinally extensive transverse myelitis in adults, certain types of cerebral phenotypes that we can get into, you would want to consider ordering MOG antibodies too.   Dr Smith: Now, you point out in the article that it's really important that laboratories use the cell-based assay for MOG as opposed to an ELISA, for instance. Is this something folks need to be very attentive to, or are all of the commercial laboratories now using a cell-based assay?   Dr Flanagan: Yeah. I think all of the commercial labs are using cell-based assays, so we don't really get into much of an issue. There are some differences between serum and CSF, so really, serum is the optimal sample to order. There is also some differences between the live cell-based assay and the fixed cell-based assay, where the live cell-based assay may have some advantages in terms of sensitivity. And then CSF is kind of still under evaluation about its role in the condition. So in general, it's a serum test. And then we have to remember that the antibody tends to be highest at the onset, and then it goes down over time. So, if you delay your testing or you're testing a patient long after the condition, it can go negative, for example. So it tends to be highest both around the relapses and particularly at the onset of the condition.   Dr Smith: You mentioned earlier that the test is sticky, which I take to mean that there is some risk for low-titer false positives. How do you navigate that situation? When should we be suspicious about a false positive?   Dr Flanagan: Yeah. I think there's some very useful features that can help you. You know, the main differential diagnosis is going to be multiple sclerosis, particularly in the US, in regions of the northern US where MS is particularly common. So, you really wanna be making sure that if you get a positive result, low positive, that it's not multiple sclerosis. And some of the best discriminating features are CSF oligoclonal bands. They're about 85% in MS and about 15% in MOG, so an easy number to remember, 85 and 15. And then the lesions in MOG, the brain lesions, tend to disappear over time. So, if you have the advantage of that follow-up MRI a year down the line, about 70% of lesions in MOGAD will resolve, while in MS, as we know, the term means multiple scars, so the MS lesions tend to persist over time. So, they are two quite useful features that can help discriminate.   Dr Smith: And how about specific phenotypes or areas of involvement or imaging abnormalities that suggest MOG? One of the things I found really interesting in your article is there are a host of different syndromes that I think had largely been previously described, many of them, that became clear later that these were really tied to MOG antibodies. Presumably, that's helpful in interpreting the antibody assay in that patients who have, perhaps, a borderline low titer, for instance, but have a very typical phenotype are more likely to have MOG than those who have a more clearly MS-type phenotype.   Dr Flanagan: Yeah, absolutely right. Yes. So, there's certain phenotypes that we don't tend to see with MS. The acute disseminated encephalomyelitis, or ADEM, is one that's particularly common in children. And about half of people that have ADEM will be positive for the MOG antibody. So that's a syndrome you need to look out for, which would be often in children, encephalopathy, and they would have multifocal white matter lesions, sometimes involving the gray matter. A second syndrome that was an interesting discovery from a Japanese group was this unilateral cerebral cortical encephalitis, where patients can have this swelling and T2 hyperintensity, often just on one side of the brain. And it's in the cortex, and some of those patients won't have any white matter lesions. And in that situation, it's important to order the MOG antibody, and that seems to be a specific phenotype of MOGAD. But sometimes people don't think about it because the white matter is not involved. So, if you see these patients, they often present with seizures, sometimes they even have fever accompanied by it. And if you see those patients and see this radiological feature, then you really want to consider ordering the MOG antibody too.   Dr Smith: Yeah, I found that really interesting. And I- actually, my next question is perhaps a good follow-up on that, is, what are the diagnostic pitfalls? You give a lot of examples of situations and I think some cases where it's easy to get tripped up and misdiagnose someone who has MOG with another fairly common neurological problem.   Dr Flanagan: Yeah, I think some of the things that can help you when you're determining if the MOG is a true positive or false positive is the level of the antibodies. The super high titers, if it's a clear positive or very strong positive, the likelihood is that that is much more likely to be MOGAD than those low positives just above the cutoff. So that can be useful to help you discriminate from false positives. Those lesions, again, if all the lesions persist over time, that's going to be more suggestive of multiple sclerosis. Other diagnostic pitfalls, I suppose, if it's a syndrome that's not really associated with MOG, like peripheral neuropathy or other syndromes where we'll see some case reports, but usually I would be very cautious about those kind of presentations. So usually, having the antibody at a high level, and then also if they've had other symptoms suggestive of MOGAD, like if a patient has had recurrent optic neuritis and then they have an unusual brain syndrome, or they start out with an unusual brain syndrome and then have recurrent optic neuritis. You know, there are situations that make it more likely if they're having other typical phenotypes of the MOGAD where we can kind of expand the spectrum, but we have to be careful.   Dr Smith: I was really curious about the dynamic imaging findings. And you point this out both in terms of the resolution of imaging findings, but also in that patients who have an acute MOG syndrome often have very rapid evolution of the imaging abnormalities. I'm just curious, you know, why is that, and what do you make of it? Does it have a mechanistic implication, do you think?   Dr Flanagan: I don't think we know for sure. I think there's probably a lot more happening than we see on MRIs sometimes. What sometimes can happen in about 10% of patients is the initial MRI can be normal. We don't tend to see that with multiple sclerosis or NMOSD. Then what we see is it evolving over time. So, at that time, if you do a CSF, you'll often see inflammation, but we don't see the lesions. Now, that might be because the MRI is not very good at picking up cortical involvement. That can be difficult to see in MRI. Or there could be other factors. It could be a functional effect on the MOG but without frank demyelination yet, for example. Or there could be edema that you- myelin edema that you can't see as a lesion yet on MRI. But we do see that if you repeat the MRI, sometimes it'll change a lot. So, you may go from one or two lesions on the first MRI to twenty lesions on the second MRI a week later. So, it does tend to change a lot. And then over time, those lesions also resolve. So, what I say is if it's a very suspicious situation---like a child comes in with new-onset encephalitis, has inflammatory CSF---you might wanna consider repeating that MRI down the line and seeing if it's changing. And then over time, you know, a repeat MRI a year after the onset when there's brain or spinal cord lesions can be very helpful just to make sure you're on the right track, because lots of those lesions will then disappear, and that's a very clear discriminator from multiple sclerosis.   Dr Smith: Yeah, thanks. I mean, I was wondering the same thing about whether that particular feature might imply, you know, a functional abnormality as opposed to more of a structural abnormality. So probably a lot more to learn as we move forward. There are now consensus diagnostic criteria that were published a couple of years ago. I think you've already touched on kind of the general approach, but do you want to speak to those? I found your summary pretty helpful.   Dr Flanagan: Yeah, I think that those criteria are quite useful. They have three main parts to them. The first part is having a characteristic clinical syndrome. So, we talked about ADEM, we talked about cerebral cortical encephalitis, transverse myelitis that's often longitudinally extensive, and optic neuritis being the main syndromes, but sometimes other brainstem or cerebellar involvement can be seen. And then the second part is having a positive MOG antibody. And then there's some caveats there. So, if you have a high positive, then you don't really need any additional supportive criteria. On the other hand, if you're low positive, to get at those sticky antibodies that make sure it's not a false positive, you need some additional supportive clinical or MRI criteria. Or if you're only positive in CSF, you need that additional criteria. You also need to be negative for the aquaporin-4 antibody, because they can overlap clinically. And some of those supportive criteria are things that we talked about a little bit earlier, longer lesions within the optic nerve, bilateral involvement, involvement of the nerve sheath or optic disc edema. This is a situation, MOG antibody disease, where your fundoscope is useful and looking in the back of the eye and seeing swelling, because we don't tend to see that quite as often. It's less common in multiple sclerosis, but we often see prominent edema in MOGAD. And then in the spinal cord, the lesions tend to be central in the cord. Sometimes they form this H sign where it's restricted to the gray matter, and they tend to be longer, sometimes involving the conus. Patients will often have neurogenic bowel or bladder. And then in the brain, deep gray involvement, those large lesions along the cortex with swelling are some of the typical features. And then the final step is exclusion of another diagnosis. Just like with any test that we do in neurology, our final step is going to be to put that into context. So that's just a normal thing that we will always do when we get a group of test results back that we don't know what it means. We have to put it into context. So, make sure it's not multiple sclerosis, everything else does not look like multiple sclerosis, and then you can be on your way to make a diagnosis.   Dr Smith: Definitely encourage listeners to read your article. I guess I say that with every time I- or with everyone I talk to for Continuum Audio, but the images are really fantastic and the cases are fantastic. So, everything you've described is well-illustrated, including really nice schematic sort of diagrams that help differentiate NMO from MOG and MS. So, if you like MRI scans and good imaging frameworks, then this is the article for you.   Dr Flanagan: I think that's true, and the other thing is that the imaging is quite helpful because it takes a while for that antibody to come back. We're lucky at Mayo Clinic, if you work here, it, it comes back faster for you. But for many places, that time of sending it in, so a lot of times you don't know right away. So, looking at scrutinizing that MRI can be very helpful to guide you on your way and to know what you're dealing with and how to approach both the acute treatment and plans to have potentially a steroid taper after the acute treatment and those kind of things that can help guide you in that regard.   Dr Smith: Yeah. So, let's talk about treatment. You know, what's your approach to treating a patient who has an acute demyelinating syndrome related to MOG?   Dr Flanagan: So similar to other things, MOG is very steroid responsive. So, we use high-dose IV methylprednisolone in adults. That would be one gram IV for five days. And then we also will sometimes use oral steroids, twelve hundred and fifty milligrams. That's a bit of a hassle because it's twenty-five fifty-milligram tablets, it doesn't come in a larger tablet version. But it's very helpful to patients because they can get started on it right away. You don't have to set up an infusion center. So, we have used those oral steroids often in people who don't have access to an infusion center, are not in the hospital. And particularly as it's often optic neuritis, some of those patients are seen in the outpatient setting, so we can get in with treatment quickly. In patients where it's more severe, it doesn't recover quickly with steroids, then we would consider escalating to plasma exchange as our second-line treatment, and there's some retrospective data that suggests that plasma exchange can be useful. That's gonna be particularly for those people who don't have that quick response to steroids, or maybe more severe phenotypes like that brain involvement with ADEM or cerebral cortical encephalitis, where those patients might be in the hospital and quite unwell. I will say, we might get on to this, that sometimes MOG can be very, very severe and even fulminant, where there can be increased intracranial pressure, and these patients can be in the ICU, and it can be life-threatening. And so, it's really important to treat those patients aggressively, and some patients have even required hemicraniectomy or additional treatment. Sometimes IL-6 blocking medications have been used in that situation. So, monitoring and treating increased intracranial pressure in those rare patients, probably 2 or 3% that have the very severe attack, is important.   Dr Smith: I think one of the things I found interesting, and then I'd love to get your feedback on this, is that most patients with MOG seem to have a very readily treatable disorder that's monophasic, right? You treat them with steroids, and they do well. On the other extreme, there are these patients that have a much more malignant presentation, and there are some that sound like they benefit from prophylactic or some chronic therapy. What's your approach, right? In MS, we do serial scans to monitor, and obviously, our patients are on, you know, chronic disease-modifying therapy. How do you decide when you're going to provide some sort of prophylactic therapy? How do you monitor it? How long do you continue it?   Dr Flanagan: That's a great point. We don't know for sure yet, but I think for the most part, our approach has been if the patient has a single episode, they recover well from that episode. So, if that's optic neuritis, they're back to twenty/twenty vision. They have recovered well. We don't tend to use chronic maintenance immunotherapy. Sometimes after the first attack, we'll do a little bit of a slow taper, maybe over four, six weeks. We have done longer than that. And then we won't place them on any long-term treatment, because it's about 50% of patients that may have a monophasic disease, so we don't want to treat all those people who are destined never to have another relapse. On the other hand, if a patient had a very severe episode, they're in the ICU, they're intubated, some of those patients then afterwards we will start them at least temporarily on an attack prevention medication for at least a few years to get them through. Some patients will be very fearful of future relapses in that situation. Or if they don't recover well, if they're blind in one eye after an episode and then their other eye is vulnerable, or they're left with some residual deficits neurologically from a myelitis, then we would often sometimes put those patients after the first attack. But most of the time, we're gonna wait and see if they get that second attack, and then once they have the second attack, that is when we would consider a steroid-sparing medication. But I will say that there's no proven medications. We don't have any clinical trial data available yet. So some of those patients with relapsing disease, we'll either try to enroll them in a clinical trial, or we'll use an off-label treatment to try and manage their disease based on what we've learned from neuromyelitis optica or from multiple sclerosis. A few different options seem to be better, and we can maybe get into that too.   Dr Smith: Yeah, let's go there. So, what options are there? You mentioned in more fulminant disease IL-6 inhibitors, and by that I assume you mean tocilizumab, but what are the options when you want to use prophylactic therapy?   Dr Flanagan: So, that tocilizumab can be beneficial in the very acute situation, in that malignant situation. But also as an attack prevention treatment, the IL-6 blockers seem to- some of the retrospective data seems to look like it works reasonably well, so we work and see if we can get that approved. Another medication that can work well is IVIG or subcutaneous immunoglobulin as a maintenance treatment, so we would sometimes give that, like, at least one gram per kilogram once a month. The benefit of that is it doesn't lower your immune system, so there's some advantages there, particularly in people who may be more prone to infections, older people. So, we'll sometimes use that. But we do get into a lot of challenges with insurance coverage, and it can be difficult to get these approved by insurance because we only have retrospective data out there. So then for some patients, if they're in a region where there's a clinical trial available, we might try to enroll them in a clinical trial. And there are some clinical trials underway now, so hopefully in the future we'll be able to have some FDA-approved medications that can have some Class 1 data that we can follow. Because it's hard when you're just following retrospective data or anecdotal reports, it's a little bit difficult to know exactly how well you're doing with your treatments.   Dr Smith: Well, Eoin, I wonder if we could finish up by just looking into the future, right? I mean, it sounds like a fun patient population to take care of because you've got lots of great therapies and can have a durable impact. But sure would be nice to have more evidence-based therapies and an FDA approval. What trials are going on? What's the future look like?   Dr Flanagan: Yep. So, there's some trials going on in the- a couple of worldwide trials. One is on an FCRN blocker called rozanolixizumab, which is kind of like a plasma exchange-type treatment which removes your antibodies, and it's a weekly subcutaneous treatment where adults are enrolled. And the second one is called satralizumab, which is another IL-6 blocking medication. And again, that one's given once monthly under the skin. And the trial for that also includes children down to age eighteen, so for adolescents, too, that can be an option. There are trials, I believe, in Asia for tocilizumab too, and there's one starting in Australia for rituximab. So, the good news is that we're going to have some really good data down the line for lots of different agents, and we'll be able to figure out which treatments work. And this will be really of great benefit to our patients when we get that Class 1 data to kind of guide us on what we should be using and really build on the success of some of the other conditions like neuromyelitis optica spectrum disorder, where we now have four or five approved, medications that work very well.   Dr Smith: Well, Eoin, thank you. This is a great conversation. I will say that it... the topic that I was a little intimidated about. I'm a simple peripheral nerve guy, as you know. But I think moreso than any other Continuum article I've read recently, I'm, like, loaded for bear. I can't wait to go back on the inpatient service and look for some MOG patients, because your article really left me feeling kind of prepared to think through this in a clinical setting. So, thank you for the conversation, and congratulations on a really wonderful piece for Continuum.   Dr Flanagan: Yeah, thanks so much. Always a great honor to be involved in the Continuum, and thanks to all the readers out there.   Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

JURY DUTY PRESENTS: COMPANY RETREAT SERIES REVIEW As part of our ongoing commitment to workplace synergy and content optimization, the One Of Us Screener Squad has asked Felix, Eoin, and T.C. to complete a comprehensive evaluation of this recent entry into the hidden camera comedy genre. This innovative offsite simulation places a group of employees […]

JURY DUTY PRESENTS: COMPANY RETREAT SERIES REVIEW As part of our ongoing commitment to workplace synergy and content optimization, the One Of Us Screener Squad has asked Felix, Eoin, and T.C. to complete a comprehensive evaluation of this recent entry into the hidden camera comedy genre. This innovative offsite simulation places a group of employees […]

Trying your best… but still feel like you can't get it “right”?In this episode, Eoin speaks directly to the frustration, uncertainty, and mental load that comes with Type 1 Diabetes when things feel unpredictable.He explains why it's not your fault, why effort isn't the issue, and how shifting from reacting to understanding can completely change the way you manage your blood sugars, and how you feel day to day.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

In memory of Clannad's Moya Brennan, who has passed away at the age of 73, we're resharing her conversation with Eoin Sheahan recorded in her family's pub in the heart of Gweedore ahead of the 2025 All Ireland Football final. She shared stories of Clannad's and her sister Enya's beginnings, the music and sporting history of the area, and her own influences.

In memory of Clannad's Moya Brennan, who has passed away at the age of 73, we're resharing her conversation with Eoin Sheahan recorded in her family's pub in the heart of Gweedore ahead of the 2025 All Ireland Football final. She shared stories of Clannad's and her sister Enya's beginnings, the music and sporting history of the area, and her own influences.

Iascaire Bhaile na nGall ag trácht ar Gharbh Shíon na gCuach i gCorca Dhuibhne – beidh tús leis amárach.

At the recent Launch of the Leinster SHC in Kinnitty Castle, Kilkenny star Eoin Cody spoke to Sean and clearly outlined how Kilkenny have focused on this game for the past six weeks since the heavy loss to Galway in the League.

Part of Eoin's chat with Michelle Law, an Honorary Professor at the University of Exeter, co-author of the latest EASD (European Association for the Study of Diabetes) guideline on Diabetes distress, and someone who has been living with Type 1 Diabetes for over 18 years.Alongside her academic work, Michelle shares honest and unfiltered insights on life with Diabetes through her writing, and has become a leading voice in helping people better understand the emotional side of this condition.She has also been involved in advocacy at the highest level, including speaking in Parliament on Diabetes technology and access, bringing real lived experience into important conversations around care.In this episode, we dive into Diabetes burnout, the mental load of day to day management, and what it really means to live well with Type 1 beyond just the numbers.Michelle's blog: pumpsandpricks.comArticle on Diabetes burnout: Diabetes BurnoutSpeaking at Parliament on Diabetes tech: pumpsandpricks.comAs always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Today's guest is Michelle Law, an Honorary Professor at the University of Exeter, co-author of the latest EASD (European Association for the Study of Diabetes) guideline on Diabetes distress, and someone who has been living with Type 1 Diabetes for over 18 years.Alongside her academic work, Michelle shares honest and unfiltered insights on life with Diabetes through her writing, and has become a leading voice in helping people better understand the emotional side of this condition.She has also been involved in advocacy at the highest level, including speaking in Parliament on Diabetes technology and access, bringing real lived experience into important conversations around care.In this episode, we dive into Diabetes burnout, the mental load of day to day management, and what it really means to live well with Type 1 beyond just the numbers.Michelle's blog: pumpsandpricks.comArticle on Diabetes burnout: Diabetes BurnoutSpeaking at Parliament on Diabetes tech: pumpsandpricks.comAs always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

What if we had a former CEO who can now speak freely about what is really happening in retail without any filters? Well, we are so fired up to have Eoin Comerford join the show. He is the former CEO for years at Moosejaw, a regional outdoor specialty retailer that was bought by Walmart, then Dicks Sporting Goods. Eoin is the host of Outdoor Unfiltered and the founder of Outsize Consulting. He breaks down the volatility to REI's business over the last few years and how Outdoor retail and ecommerce has evolved. We did talk through the evolution of trade shows in both the outdoor/running and other industries. So smart and Hayley and Scott learned a ton about business, retail and what brands need to do in this current landscape.  Always Off Brand is always a Laugh & Learn!    FEEDSPOT TOP 10 Retail Podcast! https://podcast.feedspot.com/retail_podcasts/?feedid=5770554&_src=f2_featured_email   Guest: Eoin Comerford   LinkedIn:https://www.linkedin.com/in/eoincomerford/ Podcast, Outdoor Unfiltered - https://podcasts.apple.com/es/podcast/outdoor-unfiltered/id1880194533?l=en-GB Outsized Consulting: https://www.outsizeconsulting.com/ QUICKFIRE Info:   Website: https://www.quickfirenow.com/ Email the Show: info@quickfirenow.com  Talk to us on Social: Facebook: https://www.facebook.com/quickfireproductions Instagram: https://www.instagram.com/quickfire__/ TikTok: https://www.tiktok.com/@quickfiremarketing LinkedIn : https://www.linkedin.com/company/quickfire-productions-llc/about/ Sports podcast Scott has been doing since 2017, Scott & Tim Sports Show part of Somethin About Nothin:  https://podcasts.apple.com/us/podcast/somethin-about-nothin/id1306950451 HOSTS: Summer Jubelirer has been in digital commerce and marketing for over 17 years. After spending many years working for digital and ecommerce agencies working with multi-million dollar brands and running teams of Account Managers, she is now the Amazon Manager at OLLY PBC.   LinkedIn https://www.linkedin.com/in/summerjubelirer/   Scott Ohsman has been working with brands for over 30 years in retail, online and has launched over 200 brands on Amazon. Mr. Ohsman has been managing brands on Amazon for 19yrs. Owning his own sales and marketing agency in the Pacific NW, is now VP of Digital Commerce for Quickfire LLC. Producer and Co-Host for the top 5 retail podcast, Always Off Brand. He also produces the Brain Driven Brands Podcast featuring leading Consumer Behaviorist Sarah Levinger. Scott has been a featured speaker at national trade shows and has developed distribution strategies for many top brands. LinkedIn https://www.linkedin.com/in/scott-ohsman-861196a6/   Hayley Brucker has been working in retail and with Amazon for years. Hayley has extensive experience in digital advertising, both seller and vendor central on Amazon. Hayley lives in North Carolina.  LinkedIn -https://www.linkedin.com/in/hayley-brucker-1945bb229/   Huge thanks to Cytrus our show theme music "Office Party" available wherever you get your music. Check them out here: Facebook https://www.facebook.com/cytrusmusic Instagram https://www.instagram.com/cytrusmusic/ Twitter https://twitter.com/cytrusmusic SPOTIFY: https://open.spotify.com/artist/6VrNLN6Thj1iUMsiL4Yt5q?si=MeRsjqYfQiafl0f021kHwg APPLE MUSIC https://music.apple.com/us/artist/cytrus/1462321449   "Always Off Brand" is part of the Quickfire Podcast Network and produced by Quickfire LLC.  

In this episode, Eoin breaks down how he kept his blood sugar stable during a 21K run, a half marathon (@insuleoin).He walks through his insulin strategy before, during, and after the race, how he timed his carbohydrates, and the role caffeine played in performance.Whether you have Type 1 Diabetes or just want to understand how careful planning impacts endurance, you'll get practical insights from this experience. Tune in for a deep dive into balancing glucose and endurance.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Eoin Sheahan and Stuey Byrne are joined by Irish journalist Ian Willoughby, who is based in the Czechia, to preview tomorrow's match and run through the Czech back pages to get an idea of what the build up to the playoff semi-final is like from the opposition's perspective.Irish football on Off The Ball with Cadbury | #PaintMarchGreen

Part 2 of Eoin's chat with Harriet Jaxxon (@harrietjaxxon).Many of you will know her from international stages, from Boiler Room sets to shows in New York and across Europe. She is building a serious name for herself in the global DJ scene.What a lot of people do not know is that she has been living with Type 1 diabetes since she was 17, diagnosed completely out of the blue.She is very honest about it. It was not some inspirational turning point. It was disruptive. Life altering. In her words, a complete “vibe kill”. And even now, while it is more manageable, it is still something she carries every single day.What stands out to me is how she has integrated that reality into her life. The resilience. The discipline. The mental toughness that comes with managing a chronic condition daily. Those traits have shaped not only her character, but her success.This conversation is real, grounded, and powerful.See and hear more from Harriet:Boiler Room set hereLinks to music hereInstagram hereAs always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Today's guest is Harriet Jaxxon (@harrietjaxxon).Many of you will know her from international stages, from Boiler Room sets to shows in New York and across Europe. She is building a serious name for herself in the global DJ scene.What a lot of people do not know is that she has been living with Type 1 diabetes since she was 17, diagnosed completely out of the blue.She is very honest about it. It was not some inspirational turning point. It was disruptive. Life altering. In her words, a complete “vibe kill”. And even now, while it is more manageable, it is still something she carries every single day.What stands out to me is how she has integrated that reality into her life. The resilience. The discipline. The mental toughness that comes with managing a chronic condition daily. Those traits have shaped not only her character, but her success.This conversation is real, grounded, and powerful.See and hear more from Harriet:Boiler Room set hereLinks to music hereInstagram hereAs always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Part 2 of Eoin's chat with Melanie Stephenson-Gray (@lifesportdiabetes).Today's guest is someone who truly represents what's possible with Type 1 Diabetes.Melanie Stephenson-Gray was diagnosed at just 13 years old and, instead of letting it limit her, she chose to take back control through sport. She went on to become an international sprinter, representing her country more than 25 times in the 100 and 200 meters and captaining her national team. She was featured in a Nike campaign during the London 2012 Olympics and even carried the Olympic torch in front of over 20,000 people.Over the years living with Type 1, Melanie has experienced the full evolution of Diabetes management; from multiple daily injections to automated insulin pump therapy. She's also a trained dietitian, a diabetes leader, and passionate advocate, committed to making life easier for others living with the condition.This is a conversation about resilience, high performance, and what it really takes to thrive with Type 1 Diabetes at the elite level of sport.See and hear more from Melanie here:https://www.lifesportdiabetes.co.uk/As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

In today's episode Eoin chats with Melanie Stephenson-Gray (@lifesportdiabetes).Today's guest is someone who truly represents what's possible with Type 1 Diabetes.Melanie Stephenson-Gray was diagnosed at just 13 years old and, instead of letting it limit her, she chose to take back control through sport. She went on to become an international sprinter, representing her country more than 25 times in the 100 and 200 meters and captaining her national team. She was featured in a Nike campaign during the London 2012 Olympics and even carried the Olympic torch in front of over 20,000 people.Over the years living with Type 1, Melanie has experienced the full evolution of Diabetes management; from multiple daily injections to automated insulin pump therapy. She's also a trained dietitian, a diabetes leader, and passionate advocate, committed to making life easier for others living with the condition.This is a conversation about resilience, high performance, and what it really takes to thrive with Type 1 Diabetes at the elite level of sport.See and hear more from Melanie here:https://www.lifesportdiabetes.co.uk/As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.